Harnessing Nature: Computational and Experimental Insights Into Ipomoea obscura Metabolites for Bladder Cancer Therapy
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Saravana Prabha Poochi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, India. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Plant Extracts, Ipomoea, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ipomoea obscura (L.), a medicinal plant from the Convolvulaceae family, has been traditionally used to treat various ailments. This study evaluated the in vitro cytotoxicity of its ethanolic leaf extract against human bladder cancer T24 cells and investigated its phytochemical constituents through computational methods. The extract exhibited dose‐dependent cytotoxicity with an IC 50 of 82.10 µg/mL, comparable to doxorubicin (75.04 µg/mL). Among 35 screened phytocompounds, kaempferol, oleic acid, and ursodeoxycholic acid showed strong binding affinity toward carbonic anhydrase IX (CA IX), with Glide docking scores ranging from −8.86 to −6.96 kcal/mol. These compounds formed stable Zn 2+ coordination and hydrogen‐bonding interactions within the CA IX active site. Molecular dynamics simulations confirmed the stability of the ligand–protein complexes, and MM/GBSA analysis revealed favourable binding free energies. These findings indicate that the ethanolic leaf extract of I. obscura possesses anticancer activity against bladder cancer cells, potentially mediated through CA IX inhibition. Kaempferol, oleic acid, and ursodeoxycholic acid are likely contributors and warrant further investigation for their therapeutic potential in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, India.
- Tianjin Key Laboratory For Modern Drug Delivery & High-Efficiency, State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, School of Pharmaceutical Science and Technology, Faculty o…
- Centre For Bioinformatics, Karpagam Academy of Higher Education, Coimbatore, India.
- Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, India.
- Department of Dermatology, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.
- Department of Physiology, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.
ORCID-Profile: Gopalakrishnan Velliyur Kanniappan, Muthu Thiruvengadam
Zitieren
APA
Poochi, S. P., Sundarraj, R., Raju, M. V., Kaniyur Chandrasekaran, M., Muthaiyan Ahalliya, R., Palanisamy, C. P., Velliyur Kanniappan, G., Kondapavuluri, B. K., & Thiruvengadam, M. (2025). Harnessing Nature: Computational and Experimental Insights Into Ipomoea obscura Metabolites for Bladder Cancer Therapy. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500909
Vancouver
Poochi SP, Sundarraj R, Raju MV, Kaniyur Chandrasekaran M, Muthaiyan Ahalliya R, Palanisamy CP, et al. Harnessing Nature: Computational and Experimental Insights Into Ipomoea obscura Metabolites for Bladder Cancer Therapy. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500909
BibTeX
@article{Poochi2025,
author = {Poochi, Saravana Prabha and Sundarraj, Rajamanikandan and Raju, Manikandan Vani and Kaniyur Chandrasekaran, Meenakshi and Muthaiyan Ahalliya, Rathi and Palanisamy, Chella Perumal and Velliyur Kanniappan, Gopalakrishnan and Kondapavuluri, Benod Kumar and Thiruvengadam, Muthu},
title = {Harnessing Nature: Computational and Experimental Insights Into Ipomoea obscura Metabolites for Bladder Cancer Therapy},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500909}
}
EUVIMED